Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progesterone versus LH antagonist for prevention of premature LH surge in IVF cycles
IRCT20200601047630N1Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of progesterone in infertility (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: LH surge, oocyte quality and 1 more. Started Apr 2018; status: completed.
02
Drugs
progesterone
03
Conditions
infertility
Beyond the preview
Go deeper on IRCT20200601047630N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200601047630N1.